Submitted by Anonymous (not verified) on 21 January 2026 - 15:24
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 70, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 70, Status: Authorised